OMX Nordic 40
2 348,54
|
-52,20
|
-2,17 %
|
Analysen zu OMX Nordic 40-Werten
12.11.24 | ABB Neutral | JP Morgan Chase & Co. | |
11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
11.11.24 | Novo Nordisk Neutral | UBS AG | |
11.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
08.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
08.11.24 | Novo Nordisk Overweight | Barclays Capital | |
07.11.24 | Novo Nordisk Neutral | UBS AG | |
07.11.24 | Novo Nordisk Halten | DZ BANK | |
07.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
07.11.24 | AstraZeneca Sell | UBS AG | |
07.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.11.24 | Novo Nordisk Neutral | UBS AG | |
06.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
06.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.11.24 | Novo Nordisk Neutral | UBS AG | |
06.11.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
06.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
06.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
05.11.24 | AstraZeneca Sell | UBS AG | |
05.11.24 | AstraZeneca Sell | Deutsche Bank AG | |
05.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
05.11.24 | Hennes & Mauritz AB Outperform | RBC Capital Markets | |
05.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
04.11.24 | AstraZeneca Sell | UBS AG | |
04.11.24 | Novo Nordisk Neutral | UBS AG | |
04.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
04.11.24 | ABB Neutral | Goldman Sachs Group Inc. | |
04.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
04.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
01.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
31.10.24 | Novo Nordisk Buy | Deutsche Bank AG | |
31.10.24 | A.P. Moeller - Maersk A-S Neutral | UBS AG | |
30.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
29.10.24 | ABB Neutral | JP Morgan Chase & Co. | |
29.10.24 | ABB Neutral | Goldman Sachs Group Inc. | |
28.10.24 | Novo Nordisk Neutral | UBS AG | |
28.10.24 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
25.10.24 | Volvo AB Neutral | UBS AG | |
25.10.24 | AstraZeneca Overweight | JP Morgan Chase & Co. |
HOT STOCKS DER LETZTEN 3 TAGE
Volvo AB | 5 |
ABB | 5 |
Novo Nordisk | 2 |
AstraZeneca | 1 |